Thomson Medical Group Ltd. · SGX:A50
Thomson Medical — FY2023 Earnings Presentation
19 slides from Thomson Medical's earnings presentation, Sep 7, 2023
Slide 1: FY2023 Results Briefing
CONFIDENTIAL 7 September 2023 THOMSON MEDICAL GROUP LIMITED FY2023 Results Briefing 0
Slide 2: Disclaimer
Disclaimer ANNOUNCEMENT SHALL NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY SECURITIES IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES OR ELSEWHERE. For the purposes of this disclaimer, this presentation (“Presentation”) shall mean and include the slides herein, the oral p
Slide 3: Group Overview, FY2023 Financial Highlights, Future Growth Plans
Strictly Private & Confidential 1 Group Overview 2 FY2023 Financial Highlights 3 Future Growth Plans
Slide 4: Group Overview
1 Group Overview Confidential I 3
Slide 5: Key Businesses
Key Businesses 100% One of the largest private providers of healthcare services for women and children in Singapore 37 clinics and centres today compared to 16 in 2010 S$260m FY23 Revenue Multi-disciplinary healthcare company listed on ~70% Bursa Malaysia Operates Thomson Hospital Kota Daman
Slide 6: Thomson Medical Pte Ltd ("TMPL")
Thomson Medical Pte Ltd (“TMPL”) Hospital Operations & Ancillary Services Established in 1979, TMPL owns and operates Thomson Medical Centre (“TMC”) and a network of specialist medical clinics and facilities providing outpatient women and children healthcare services, as well as diagnostic imaging,
Slide 7: TMC Life Sciences Berhad ("TMCLS")
TMC Life Sciences Berhad (“TMCLS”) Hospital Operations & Ancillary Services In 2008, TMCLS established Thomson Hospital Kota Damansara (“THKD”). THKD is its flagship multi-disciplinary tertiary care centre equipped with advanced medical technology and infrastructure to deliver quality and affordable
Slide 8: Healthcare Assets in Singapore and Malaysia
Healthcare Assets in Singapore and Malaysia Singapore Malaysia 187 37 308 6 1 TCM clinic & licensed beds(1) clinics & centres licensed beds(1)(2) fertility centres 1 pharmacy Sembawang Choa Chu Kang Novena Punggol Medical Centre Penang Sengkang Bukit Batok/ Bukit Panjang Serangoon Future growth Tamp
Slide 9: FV Hospital: A world-class healthcare delivery platform in Vietnam
tes: rce: FV Hospital: A world-class healthcare delivery platform in Vietnam Snapshot of the FV Group’s Network FV Group overview FV Hanoi City • Years in operation: 20+ Hospital 1 ACC Clinic • Location: District 7, Ho Chi Minh City (“Hanoi Clinic”) • Modern multi-specialty private tertiary care hos
Slide 10: FY2023 Financial Highlights
2 FY2023 Financial Highlights Confidential I 9
Slide 11: Group Financial Highlights – FY2023
Group Financial Highlights – FY2023 Revenue Growth and Healthy Balance Sheet Final Steady Profit Dividend 6.6% FY2023 Revenue Successfully redeemed Board of Directors $355.8m S$225.0m bonds recommend final dividend of due in July 2022 with a 0.040 cents per share revolving loan FY2023 EBITDA 5.8% $1
Slide 12: Historical Financial Highlights
Historical Financial Highlights REVENUE EBITDA PROFIT AFTER TAX Revenue by Geographical EBITDA by Geographical PAT by Geographical Segments ($mil) Segments ($mil) Segments ($mil) YoY YoY ↑6.6% ↓5.8% 355.8 109.7 YoY 333.7 103.3 ↓29.9% YoY YoY 15.1 ↑43.7% ↑20.6% 95.4 79.1 58.6 21.7 240.4 66.8 12.6 66.
Slide 13: Geographical Segments – FY2023
Geographical Segments – FY2023 Revenue EBITDA (S$ in millions) (S$ in millions) $79.1m $95.4m $15.1m $21.7m 24% 27% 14% 21% FY2022 FY2023 FY2022 FY2023 $333.7m $355.8m $109.7m $103.3m $254.6m $260.4m $94.6m $81.6m 76% 73% 86% 79% Singapore Malaysia EBITDA margin Segments FY2021 FY2022 FY2023 Singapo
Slide 14: Key Leverage Ratios
KEY LEVERAGE RATIOS S$’m FY2021 FY2022 FY2023 Total Debts 619.4 629.1 747.8 Cash (122.7) (161.6) (286.6) Net Debts 496.7 467.5 461.2 Equity 566.0 608.3 575.4 EBITDA 66.8 109.7 103.3 Net Debts / Equity 0.9x 0.8x 0.8x Net Debts / EBITDA 7.4x 4.3x 4.5x Confidential I 13
Slide 15: Key Operating Statistics
Key Operating Statistics OFPROFIT & LOSS – GROUP (2H FY2022) IT & LOSS – GROUP (2H FY2022) PROFIT & LOSS – GROUP (2H FY2022) FY2021 FY2022 FY2023 LICENSED BEDS1 Singapore 187 187 187 Malaysia 205 308 350 Total 392 495 537 OPERATIONAL BEDS2 Singapore 181 181 178 Malaysia 205 299 314 Total 386 480 492
Slide 16: Key Operating Statistics
Key Operating Statistics FY2021 FY2022 FY2023 NUMBER OF INPATIENT Singapore 20,402 20,972 20,315 Malaysia 18,806 23,107 29,390 Total 39,208 44,079 49,705 NUMBER OF OUTPATIENT Singapore 277,398 308,308 288,638 Malaysia 166,254 183,470 171,613 Total 443,652 491,778 460,251 INPATIENT ABS1 Singapore S$3
Slide 17: Future Growth Plans
3 Future Growth Plans Confidential I 16
Slide 18: TMG Going Forward: Firing on all Cylinders
TMG Going Forward: Firing on all Cylinders • Strategic high-value healthcare markets • Markets offering high growth potential, especially leveraging the Group’s Regional stronghold in Singapore, Malaysia and Vietnam Expansion • A localised approach to each market to maximise each geography’s unique
Slide 19: Thank You!
Thomson Medical Group Limited THANK YOU! 101 Thomson Road #20-04/05 United Square Singapore 307591 Confidential I 18